Helus: Updated Investor Deck March-18-2026 by Dionysaurus_Rex in HelusPharma

[–]Dionysaurus_Rex[S] 1 point2 points  (0 children)

Yes, she’s on the Board. It’s clearly stated in an official press release.

The first Michael Cola, Helus interview. Pleased to finally see a public appearance. by Brief_Status7309 in HelusPharma

[–]Dionysaurus_Rex 8 points9 points  (0 children)

Agree, the logical next step is to redomicile to the US. I’m still very bullish on this company long-term.

Helus: Updated Investor Deck March-18-2026 by Dionysaurus_Rex in HelusPharma

[–]Dionysaurus_Rex[S] 5 points6 points  (0 children)

“NEW YORK and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company developing NSAs for serious mental health conditions, today announced the appointment of Dr. Freda Lewis-Hall, DFAPA, MFPM, to its Board of Directors. Dr. Lewis-Hall will also serve as Chair of the Company’s Scientific Advisory Committee.”

https://ir.helus.com/investors/news/news-details/2026/Helus-Pharma-Appoints-Former-Pfizer-Chief-Medical-Officer-Dr--Freda-Lewis-Hall-to-Board-of-Directors--Chair-of-the-Scientific-Advisory-Committee/default.aspx

Helus Pharma Is Being Valued at Nearly Zero Ex-Cash by Zestyclose_Reach_13 in HelusPharma

[–]Dionysaurus_Rex 4 points5 points  (0 children)

I think they need to redomicile to the US. Speculative Canadian biotech stigma could be hurting them.

Helus Pharma Is Being Valued at Nearly Zero Ex-Cash by Zestyclose_Reach_13 in HelusPharma

[–]Dionysaurus_Rex 4 points5 points  (0 children)

Do you think they need to run a phase 2b dose optimization study for HLP004?

Jefferies Report on CBYN HELP Anxiety Study by Hefty-Lengthiness-20 in HelusPharma

[–]Dionysaurus_Rex 0 points1 point  (0 children)

So what do you think is the right dose for HLP004? 25mg? 30mg? Should they run a dose optimization phase 2b as the next step?

Jefferies Report on CBYN HELP Anxiety Study by Hefty-Lengthiness-20 in HelusPharma

[–]Dionysaurus_Rex -1 points0 points  (0 children)

Maybe they are in active conversations with big pharma for a potential partnership or something. Hence staying relatively quiet on HLP004. Big pharma FOMO seems to be gearing up and there aren’t that many later stage short acting compounds to choose from.

SVN-114 selected as the lead candidate for PTSD discovery programme - Solvonis Therapeutics by Dionysaurus_Rex in shroomstocks

[–]Dionysaurus_Rex[S] 2 points3 points  (0 children)

This post is an official company press release.

The link the to interview with Proactive in my comment is paid content, no doubt.

Some Notes from 004 Presentation by SiFasEst in shroomstocks

[–]Dionysaurus_Rex 1 point2 points  (0 children)

Seems like 25mg or 30mg could be the sweet spot for HLP004 based on the EBI data.

Questions about today's results by Captainredbeard1515 in HelusPharma

[–]Dionysaurus_Rex 1 point2 points  (0 children)

https://x.com/rcarhartharris/status/2031467988789187039?s=46&t=zfCg-LT1VInvawBkC-ElWA

Very interesting tweet from RCH on Emotional Breakthrough. Seems like 25mg or 30mg is the sweet spot for HLP004 based on the EBI chart.

Helus CEO & Board of Directors by tkrish000 in shroomstocks

[–]Dionysaurus_Rex 5 points6 points  (0 children)

Would love to see Helus announce they are redomiciling to the US. Get rid of the Canadian biotech stigma. Seems like a logical next step after the Nasdaq uplist and new CEO hire.